Skip to main content
fghjkjhb

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Digital Health Applications (DiGAs) on a Fast Track: Insights From a Data-Driven Analysis of Prescribable Digital Therapeutics in Germany From 2020 to Mid-2024

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Goeldner et al. analyzed the evolving ecosystem of digital health applications (DiGAs) in Germany, leveraging a data-driven approach based on public sources to assess market dynamics, pricing trends, and clinical evidence. The study highlighted the challenges of achieving permanent listing, driven by the rigorous requirements to demonstrate clinical efficacy, with a consistent reliance on randomized controlled trials. The authors emphasized the need for innovative study designs and a stronger focus on patient-relevant outcomes to facilitate the integration of DiGAs into Germany’s healthcare system.

Access the full-text article here.